BioCentury | Nov 14, 2020
Emerging Company Profile

Metagenomi hunts for new gene editing systems with $65M series A

...Medicine Inc. (NASDAQ:EDIT),  Arbor Biotechnologies Inc. and Twelve Bio...
BioCentury | Oct 10, 2020
Product Development

Next-generation CRISPR technologies keep on building

...those companies are working with Cas12a, including Twelve Bio...
BioCentury | Mar 13, 2020
Emerging Company Profile

Twelve Bio: Building a plug-and-play CRISPR platform with Cas12a variants

...Danish newco Twelve Bio is building a CRISPR-Cas12a toolbox comprising a suite of Cas12a variants that are...
...safe to use than the wild type Cas12a enzyme for both diagnostic and therapeutic applications. Twelve Bio...
...Biology For Diagnostics ” ; “ Mammoth Makes Dx CRISPR ” ). Stella told BioCentury Twelve Bio...
Items per page:
1 - 3 of 3
BioCentury | Nov 14, 2020
Emerging Company Profile

Metagenomi hunts for new gene editing systems with $65M series A

...Medicine Inc. (NASDAQ:EDIT),  Arbor Biotechnologies Inc. and Twelve Bio...
BioCentury | Oct 10, 2020
Product Development

Next-generation CRISPR technologies keep on building

...those companies are working with Cas12a, including Twelve Bio...
BioCentury | Mar 13, 2020
Emerging Company Profile

Twelve Bio: Building a plug-and-play CRISPR platform with Cas12a variants

...Danish newco Twelve Bio is building a CRISPR-Cas12a toolbox comprising a suite of Cas12a variants that are...
...safe to use than the wild type Cas12a enzyme for both diagnostic and therapeutic applications. Twelve Bio...
...Biology For Diagnostics ” ; “ Mammoth Makes Dx CRISPR ” ). Stella told BioCentury Twelve Bio...
Items per page:
1 - 3 of 3